S 3440 · 117th Congress
A bill to amend the Federal Food, Drug, and Cosmetic Act and the Defense Production Act of 1950 to prohibit the Federal Government from limiting State access to key therapies, such as monoclonal antibodies, and from prioritizing Federal contracts over State contracts relating to purchasing supplies to combat the COVID-19 pandemic.
This bill prevents the federal government from restricting states' ability to get important COVID-19 treatments, particularly monoclonal antibodies, which are lab-made proteins that help fight the virus. During the pandemic, the federal government controlled the distribution of these treatments and other critical su…
- Sponsor
- Cruz, Ted (R-TX)
- Introduced
- 2022-01-04
- Policy area
- Health
- Latest action
- Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Digging through Congress... 🔍